We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCAB icon
1626
BioAtla
BCAB
$5.59M
-354
Closed -$61K
BCBP icon
1627
BCB Bancorp
BCBP
$163M
-18,143
Closed -$190K
BCLI
1628
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
-7,416
Closed -$63K
BCO icon
1629
Brink's
BCO
$4.61B
-4,158
Closed -$384K
BE icon
1630
Bloom Energy
BE
$64.5B
-60,168
Closed -$676K
BEKE icon
1631
KE Holdings
BEKE
$18.8B
-26,230
Closed -$360K
BGS icon
1632
B&G Foods
BGS
$282M
-247,796
Closed -$2.83M
BHP icon
1633
BHP
BHP
$230B
-13,149
Closed -$759K
BKKT icon
1634
Bakkt Inc
BKKT
$332M
-1,296
Closed -$15K
BLK icon
1635
Blackrock
BLK
$177B
-442
Closed -$368K
BLND icon
1636
Blend Labs
BLND
$404M
-109,287
Closed -$355K
BMRN icon
1637
BioMarin Pharmaceuticals
BMRN
$12.4B
-7,035
Closed -$614K
BNGO icon
1638
Bionano Genomics
BNGO
$13.2M
-9,163
Closed -$610K
BNTX icon
1639
BioNTech
BNTX
$23.5B
-3,625
Closed -$334K
BOC icon
1640
Boston Omaha
BOC
$435M
-28,166
Closed -$435K
BOX icon
1641
Box
BOX
$4.57B
-35,624
Closed -$1.01M
BRBS icon
1642
Blue Ridge Bankshares
BRBS
$333M
-39,374
Closed -$106K
BRC icon
1643
Brady Corp
BRC
$4.62B
-17,735
Closed -$1.05M
BRKR icon
1644
Bruker
BRKR
$8.09B
-5,161
Closed -$485K
BRT
1645
BRT Apartments
BRT
$273M
-19,628
Closed -$330K
BWB icon
1646
Bridgewater Bancshares
BWB
$603M
-25,158
Closed -$293K
BXC icon
1647
BlueLinx
BXC
$704M
-11,522
Closed -$1.5M
BXP icon
1648
Boston Properties
BXP
$11.1B
-9,849
Closed -$643K
BY icon
1649
Byline Bancorp
BY
$1.77B
-16,082
Closed -$349K
BBBY
1650
Bed Bath & Beyond
BBBY
$445M
-8,248
Closed -$269K

Similar funds

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.